Table 1 Baseline clinical and biochemical data

Weight (Kg)

50

–

Weight (Z-score)

−0.46

−2 − + 2

Height (cm)

159

–

Height (Z-score)

−1.10

−2 − + 2

BMI

20

–

BMI (Z-score)

0.10

−2 − + 2

PCDAI

50

< 10

Stool consistency type

6

3–4

Glucose (mmol/L)

4.5

3.3–6.1

Lactate (mmol/L)

1.8

< 2.2

Total cholesterol (mmol/L)

1.4

3.4–5.3

Triglycerides (mmol/L)

0.4

0.5–1.6

Uric acid (mmol/L)

0.26

0.13–0.39

AST (U/L)

12

0–34

ALT (U/L)

7

0–55

Albumin (g/L)

37

34–48

Creatinine (mg/dL)

0.66

0.60–1.10

Blood Urea Nitrogen (mg/dL)

13

18–45

eGFR (ml/min/1.73 m2)

132.6

100.9–133.3

White blood cells (WBC)/μL

3010

5000–15,000

Neutrophils/μL

1490

1300–8500

Lymphocytes/μL

1370

1300–8500

Hemoglobin (g/dL)

8.8

11.5–14.0

Hematocrit (%)

33

33–35

Platelets/μL

274,000

140,000–440,000

Fibrinogen (mg/dL)

233

160–350

1,5AG (μM)

155

–

1,5AG6P (μM)

1.35

–

CRP (mg/dL)

2.8

< 0.5

ESR (mm/h)

35

< 20

Adalimumab (μg/ml)

<  0.5

5–10

Anti-adalimumab IgG (ng/ml)

62.3

<  2.5

24-h urine protein (mg/24 h)

<  200

<  200

24-h urine glucose (mg/24 h)

not detected

not detected

Fecal calprotectin (μg/g)

253

<  100